<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36907733</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>03</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2518</ISSN><JournalIssue CitedMedium="Internet"><Volume>41 Suppl 1</Volume><Issue>Suppl 1</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>06</Day></PubDate></JournalIssue><Title>Vaccine</Title><ISOAbbreviation>Vaccine</ISOAbbreviation></Journal><ArticleTitle>Vaccine-derived poliovirus serotype 2 outbreaks and response in the Democratic Republic of the Congo, 2017-2021.</ArticleTitle><Pagination><StartPage>A35</StartPage><EndPage>A47</EndPage><MedlinePgn>A35-A47</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.vaccine.2023.02.042</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0264-410X(23)00177-9</ELocationID><Abstract><AbstractText>Vaccine-derived polioviruses (VDPVs) can emerge from Sabin strain poliovirus serotypes 1, 2, and 3 contained in oral poliovirus vaccine (OPV) after prolonged person-to-person transmission where population vaccination immunity against polioviruses is suboptimal. VDPVs can cause paralysis indistinguishable from wild polioviruses and outbreaks when community circulation ensues. VDPV serotype 2 outbreaks (cVDPV2) have been documented in The Democratic Republic of the Congo (DRC) since 2005. The nine cVDPV2 outbreaks detected during 2005-2012 were geographically-limited and resulted in 73 paralysis cases. No outbreaks were detected during 2013-2016. During January 1, 2017-December 31, 2021, 19 cVDPV2 outbreaks were detected in DRC. Seventeen of the 19 (including two first detected in Angola) resulted in 235 paralysis cases notified in 84 health zones in 18 of DRC's 26 provinces; no notified paralysis cases were associated with the remaining two outbreaks. The DRC-KAS-3 cVDPV2 outbreak that circulated during 2019-2021, and resulted in 101 paralysis cases in 10 provinces, was the largest recorded in DRC during the reporting period in terms of numbers of paralysis cases and geographic expanse. The 15 outbreaks occurring during 2017-early 2021 were successfully controlled with numerous supplemental immunization activities (SIAs) using monovalent OPV Sabin-strain serotype 2 (mOPV2); however, suboptimal mOPV2 vaccination coverage appears to have seeded the cVDPV2 emergences detected during semester 2, 2018 through 2021. Use of the novel OPV serotype 2 (nOPV2), designed to have greater genetic stability than mOPV2, should help DRC's efforts in controlling the more recent cVDPV2 outbreaks with a much lower risk of further seeding VDPV2 emergence. Improving nOPV2 SIA coverage should decrease the number of SIAs needed to interrupt transmission. DRC needs the support of polio eradication and Essential Immunization (EI) partners to accelerate the country's ongoing initiatives for EI strengthening, introduction of a second dose of inactivated poliovirus vaccine (IPV) to increase protection against paralysis, and improving nOPV2 SIA coverage.</AbstractText><CopyrightInformation>Copyright © 2023. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alleman</LastName><ForeName>Mary M</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Global Immunization Division, Centers for Disease Control and Prevention, Atlanta, USA. Electronic address: mea4@cdc.gov.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jorba</LastName><ForeName>Jaume</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riziki</LastName><ForeName>Yogolelo</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institut National de Recherche Biomédicale, Ministry of Public Health, Hygiene and Prevention, Democratic Republic of the Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henderson</LastName><ForeName>Elizabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mwehu</LastName><ForeName>Anicet</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Emergency Operations Center for Polio, Ministry of Public Health, Hygiene and Prevention, Democratic Republic of the Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Seakamela</LastName><ForeName>Lerato</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>National Institute for Communicable Diseases, National Health Laboratory Services, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Howard</LastName><ForeName>Wayne</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>National Institute for Communicable Diseases, National Health Laboratory Services, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kadiobo Mbule</LastName><ForeName>Albert</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Polio, Office of the Regional Director, World Health Organization, Democratic Republic of the Congo Country Office, Democratic Republic of the Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nsamba</LastName><ForeName>Renee Ntumbannji</ForeName><Initials>RN</Initials><AffiliationInfo><Affiliation>Polio, Office of the Regional Director, World Health Organization, Democratic Republic of the Congo Country Office, Democratic Republic of the Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Djawe</LastName><ForeName>Kpandja</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Polio, Office of the Regional Director, World Health Organization, Democratic Republic of the Congo Country Office, Democratic Republic of the Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yapi</LastName><ForeName>Moïse Désiré</ForeName><Initials>MD</Initials><AffiliationInfo><Affiliation>Polio, Office of the Regional Director, World Health Organization, Democratic Republic of the Congo Country Office, Democratic Republic of the Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mengouo</LastName><ForeName>Marcellin Nimpa</ForeName><Initials>MN</Initials><AffiliationInfo><Affiliation>Polio, Office of the Regional Director, World Health Organization, Democratic Republic of the Congo Country Office, Democratic Republic of the Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gumede</LastName><ForeName>Nicksy</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Polio, Office of the Regional Director, World Health Organization, Regional Office for Africa, Republic of the Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ndoutabe</LastName><ForeName>Modjirom</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Polio, Office of the Regional Director, World Health Organization, Regional Office for Africa, Republic of the Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kfutwah</LastName><ForeName>Anfumbom K W</ForeName><Initials>AKW</Initials><AffiliationInfo><Affiliation>Polio, Office of the Regional Director, World Health Organization, Regional Office for Africa, Republic of the Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Senouci</LastName><ForeName>Kamel</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Bill and Melinda Gates Foundation, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burns</LastName><ForeName>Cara C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>001</GrantID><Acronym>WHO_</Acronym><Agency>World Health Organization</Agency><Country>International</Country></Grant><Grant><GrantID>CC999999</GrantID><Acronym>ImCDC</Acronym><Agency>Intramural CDC HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Vaccine</MedlineTA><NlmUniqueID>8406899</NlmUniqueID><ISSNLinking>0264-410X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065288" MajorTopicYN="N">Serogroup</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015023" MajorTopicYN="N" Type="Geographic">Democratic Republic of the Congo</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="N">Poliovirus Vaccine, Oral</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute flaccid paralysis</Keyword><Keyword MajorTopicYN="N">Africa</Keyword><Keyword MajorTopicYN="N">Circulating vaccine-derived poliovirus type 2</Keyword><Keyword MajorTopicYN="N">Democratic Republic of the Congo</Keyword><Keyword MajorTopicYN="N">Monovalent oral polio vaccine type 2</Keyword><Keyword MajorTopicYN="N">Novel oral polio vaccine type 2</Keyword><Keyword MajorTopicYN="N">Polio eradication</Keyword><Keyword MajorTopicYN="N">Poliovirus environmental surveillance</Keyword><Keyword MajorTopicYN="N">Poliovirus outbreak response</Keyword><Keyword MajorTopicYN="N">Supplemental immunization activities</Keyword><Keyword MajorTopicYN="N">Surveillance</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>3</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>12</Day><Hour>23</Hour><Minute>5</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36907733</ArticleId><ArticleId IdType="mid">NIHMS1911458</ArticleId><ArticleId IdType="pmc">PMC10427717</ArticleId><ArticleId IdType="doi">10.1016/j.vaccine.2023.02.042</ArticleId><ArticleId IdType="pii">S0264-410X(23)00177-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Burns C.C., Diop O.M., Sutter R.W., et al. Vaccine-derived polioviruses. J Infect Dis. 2022;2014(210):S283–S293.</Citation><ArticleIdList><ArticleId IdType="pubmed">25316847</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. WHO/UNICEF estimates of national immunization coverage, WHO-UNICEF estimates of POL3 coverage. https://immunizationdata.who.int/listing.html?topic=coverage&amp;location=. Accessed 1 February 2023.</Citation></Reference><Reference><Citation>UNICEF and World Health Organization. Democratic Republic of the Congo: WHO and UNICEF estimates of immunization coverage: 2021 revision. Democratic Republic of the Congo - UNICEF Data. Accessed 22 February 2023.</Citation></Reference><Reference><Citation>Alleman MM, Wannemuehler K, Weldon W, et al. Factors contributing to outbreaks of wild poliovirus type 1 infection involving persons aged ≥15 years in the Democratic Republic of the Congo, 2010–2011, informed by a pre-outbreak poliovirus immunity assessment. J Infect Dis. 2014;210:S62–73. https://doi.org /10.1093/infdis/jiu282. Accessed 2 June 2022.</Citation><ArticleIdList><ArticleId IdType="pubmed">25316879</ArticleId></ArticleIdList></Reference><Reference><Citation>Voorman A., Hoff N.A., Doshi R.H., et al. Polio immunity and the impact of mass immunization campaigns in the Democratic Republic of the Congo. Vaccine. 2017;35:5693–5699.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5628608</ArticleId><ArticleId IdType="pubmed">28882442</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization, Democratic Republic of the Congo Country Office. Activités d’éradication de la poliomyélite (IEP), République Démocratique du Congo, weekly reports, 2010-2022. Available from the World Health Organization, Democratic Republic of the Congo Country Office.</Citation></Reference><Reference><Citation>Gumede N., Lentsoane O., Burns C.C., et al. Emergence of vaccine-derived polioviruses, Democratic Republic of Congo, 2004–2011. Emerg Infect Dis. 2022;2013(10):1583–1589.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3810735</ArticleId><ArticleId IdType="pubmed">24047933</ArticleId></ArticleIdList></Reference><Reference><Citation>Alleman M.M., Chitale R., Burns C.C., et al. Vaccine-Derived Poliovirus Outbreaks and Events — Three Provinces, Democratic Republic of the Congo, 2017. MMWR Morb Mortal Wkly Rep. 2018;67:300–305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5857197</ArticleId><ArticleId IdType="pubmed">29543791</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampton L.M., Farrell M., Ramirez-Gonzalez A., et al. Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine — Worldwide, 2016. MMWR Morb Mortal Wkly Rep. 2016;65:934–938.</Citation><ArticleIdList><ArticleId IdType="pubmed">27606675</ArticleId></ArticleIdList></Reference><Reference><Citation>Grassly N.C. Immunogenicity and Effectiveness of Routine Immunization With 1 or 2 Doses of Inactivated Poliovirus Vaccine: Systematic Review and Meta-analysis. J Infect Dis. 2022;2014(210):S439–S446.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4197908</ArticleId><ArticleId IdType="pubmed">24634499</ArticleId></ArticleIdList></Reference><Reference><Citation>Tevi-Benissan C., Okeibunor J., Maufras du Châtellier G., et al. Introduction of Inactivated Poliovirus Vaccine and Trivalent Oral Polio Vaccine/Bivalent Oral Polio Vaccine Switch in the African Region. J Infect Dis. 2017;216:S66–S75.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5853502</ArticleId><ArticleId IdType="pubmed">28838178</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorba J., Diop O.M., Iber J., et al. Update on Vaccine-Derived Polioviruses — Worldwide, January 2016–June 2017. MMWR Morb Mortal Wkly Rep. 2017;66:1185–1191.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5689216</ArticleId><ArticleId IdType="pubmed">29095803</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorba J., Diop O.M.N., Iber J., et al. Update on Vaccine-Derived Polioviruses — Worldwide, January 2017–June 2018. MMWR Morb Mortal Wkly Rep. 2018;67:1189–1194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6290814</ArticleId><ArticleId IdType="pubmed">30359342</ArticleId></ArticleIdList></Reference><Reference><Citation>Mbaeyi C., Alleman M.M., Ehrhardt D., et al. Update on Vaccine-Derived Poliovirus Outbreaks — Democratic Republic of the Congo and Horn of Africa, 2017–2018. MMWR Morb Mortal Wkly Rep. 2019;68:225–230.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6421971</ArticleId><ArticleId IdType="pubmed">30845121</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorba J., Diop O.M., Iber J., et al. Update on vaccine-derived poliovirus outbreaks—worldwide, January 2018–June 2019. MMWR Morb Mortal Wkly Rep. 2019;68:1024–1028.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6855511</ArticleId><ArticleId IdType="pubmed">31725706</ArticleId></ArticleIdList></Reference><Reference><Citation>Alleman M.M., Jorba J., Greene S.A., et al. Update on vaccine-derived poliovirus outbreaks—worldwide, July 2019–February 2020. MMWR Morb Mortal Wkly Rep. 2020;69:489–495.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7188410</ArticleId><ArticleId IdType="pubmed">32324719</ArticleId></ArticleIdList></Reference><Reference><Citation>Alleman M.M., Jorba J., Henderson E., et al. Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, January 2020–June 2021. MMWR Morb Mortal Wkly Rep. 2021;70:1691–1699.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8659190</ArticleId><ArticleId IdType="pubmed">34882653</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministry of Public Health, Hygiene and Prevention, Democratic Republic of the Congo. Fiche technique de surveillance des PFA, 27 février . Ministry of Public Health; Democratic Republic of the Congo: 2019. Available from the Expanded Programme on Immunization.</Citation></Reference><Reference><Citation>World Health Organization Regional Office for Africa. Acute flaccid paralysis surveillance field guide, January 2006. Available from the World Health Organization Regional Office for Africa.</Citation></Reference><Reference><Citation>World Health Organization, Global Polio Eradication Initiative. Global Polio Surveillance Action Plan, 2018-2020. https://polioeradication.org/wp-content/uploads/2016/07/GPEI-global-polio-surveillance-action-plan-2018-2020-EN-1.pdf. Accessed 2 June 2022.</Citation></Reference><Reference><Citation>World Health Organization, Global Polio Eradication Initiative. Guidelines on Environmental Surveillance for Detection of Polioviruses. https://polioeradication.org/wp-content/uploads/2016/07/GPLN_GuidelinesES_April2015.pdf. Accessed 22 February 2023.</Citation></Reference><Reference><Citation>Coulliette-Salmond A.D., Alleman M.M., Wilnique P., et al. Haïti Poliovirus Environmental Surveillance. Am J Trop Med Hyg. 2019;101:1240–1248.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6896891</ArticleId><ArticleId IdType="pubmed">31701857</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization, Global Polio Eradication Initiative. Reporting and classification of vaccine-derived polioviruses. https://polioeradication.org/wp-content/uploads/2016/07/VDPV_ReportingClassification.pdf. Accessed 2 June 2022.</Citation></Reference><Reference><Citation>Ministry of Public Health, Hygiene and Prevention, Democratic Republic of the Congo. Various “Bulletin hebdomadaire de riposte à l’épidémie de PVDV2c en RDC” and “Compte Rendu de la réunion du Centre des Operations d'Urgence Polio (COUP, Emergency Operations Center-Polio)”. 2018-2021. Available from the Expanded Programme on Immunization, Ministry of Public Health, Democratic Republic of the Congo.</Citation></Reference><Reference><Citation>Jorba J. Phylogenetic Analysis of Poliovirus Sequences. Methods Mol Biol. 2016;1387:227–237.</Citation><ArticleIdList><ArticleId IdType="pubmed">26983737</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization, Global Polio Eradication Initiative. Standard Operating Procedures: Responding to a poliovirus event or outbreak - Version 3 (January 2019). https://reliefweb.int/report/world/standard-operating-procedures-responding-poliovirus-event-or-outbreak-version-3-january. Accessed 2 June 2022.</Citation></Reference><Reference><Citation>Okitolonda E, Rimoin A (Kinshasa School of Public Health and UCLA Fielding School of Public Health). Rapid vaccine coverage and linked biomarker survey, children 6-23 months Haut Lomami Province, Baseline Report 2018-2019. November 2019. Available from the Kinshasa School of Public Health, Democratic Republic of the Congo.</Citation></Reference><Reference><Citation>Ministry of Public Health, Central African Republic. République Centrafricaine Rapport de Situation de la réponse aux cas de VDPV2. 2019. Available from the Expanded Programme on Immunization, Ministry of Public Health, Central African Republic.</Citation></Reference><Reference><Citation>World Health Organization, Regional Office for Africa. Outbreaks and Emergencies Bulletin. 2017-2021. Available online: https://www.afro.who.int/health-topics/disease-outbreaks/outbreaks-and-other-emergencies-updates?utm_source=Newsweaver&amp;utm_medium=email&amp;utm_term=View%20archives%20of%20this%20update%20bulletin&amp;utm_content=Tag%3AAFRO/WHE/HIM%20Outbreaks%20Weekly&amp;utm_campaign=WHO%20AFRO%20-%20Outbreaks%20and%20Emergencies%20Bulletin%20-%20Week%2022/2022&amp;page=5. Accessed 2 June 2022.</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention. Africa Kicks Out Wild Polio. 2020. https://www.cdc.gov/polio/why-it-matters/africa-kicks-out-wild-polio.htm. Accessed 2 June 2022.</Citation></Reference><Reference><Citation>Gavi, The Vaccine Alliance. Democratic Republic of Congo launches major vaccination drive. 2018. Accessed 2 June 2022.</Citation></Reference><Reference><Citation>UNICEF, Democratic Republic of Congo. Water, sanitation, and hygiene. 2021-2022. https://www.unicef.org/drcongo/en/what-we-do/water-sanitation-and-hygiene. Accessed 2 June 2022.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>